Pomegra
EliseAI raised $350 million at a $4 billion valuation, led by a16z and Bessemer, to expand its AI automation for U.S. property management and healthcare clinics.
Key Takeaways
- EliseAI raised $350M at a $4B valuation, up from $2.2B in its $250M Series E 13 months earlier.
- a16z and Bessemer co-led. Ontario Teachers' Pension Plan, Sapphire Ventures and Navitas Capital also joined.
- The company reports more than $200M in ARR and powers one in six U.S. apartment units.
Lead
EliseAI, the New York-based maker of AI agents for housing and healthcare operations, announced a $350 million round on September 29, 2026 at a $4 billion valuation. Andreessen Horowitz (a16z) and Bessemer Venture Partners co-led. Ontario Teachers' Pension Plan joined as a new investor, alongside Sapphire Ventures and Navitas Capital. The company did not label the round with a stage. Bessemer partner Sameer Dholakia joined the board.
The valuation is close to double the $2.2 billion set by the company's $250 million Series E about 13 months earlier. It is the fourth investment in the company from a16z and Bessemer since 2023.
What Does EliseAI Actually Do?
EliseAI sells AI agents that handle front-office work over voice and digital channels. In housing, that means leasing inquiries, resident services, maintenance requests, renewals and billing. In healthcare, it covers patient scheduling, intake, insurance eligibility checks, referrals and chart preparation, aimed at specialty physician groups and ambulatory clinics.
The company says its software powers one in six apartment units in the United States, and that more than 30 million Americans have interacted with the platform. In September 2026 it launched Apollo, an agentic teammate that works across property management workflows. CEO and co-founder Minna Song leads the company.
Why Did the Valuation Nearly Double in a Year?
Revenue growth is the stated reason. EliseAI reported crossing $200 million in annual recurring revenue in June 2026 and says it has doubled revenue each year for five consecutive years. At $4 billion, the valuation is about 20 times that ARR, a multiple that sits inside the range recent AI application rounds have commanded.
The figures come from the company and have not been independently audited. A 100% growth rate sustained for five years gets harder to hold as the base grows, and a repeat from $200 million would mean $400 million in ARR. The a16z and Bessemer repeat investment signals that existing backers see that path as plausible. It also means the price discipline of a new outside lead was absent, although the arrival of a Canadian pension fund adds a late-stage institutional investor to the cap table.
How Will EliseAI Use the Money?
The company plans to spend the proceeds on product development and on expanding engineering, deployment and sales teams across North America. It operates from hubs in New York, Boston, Chicago, Austin and Toronto, and plans to open a second engineering hub in San Francisco. Headcount and total capital raised were not disclosed.
Deployment staff matter more here than in typical software. Agents that touch leasing contracts, insurance verification and patient records need integration with property management systems and electronic health records, and that work is slow and customer-specific. The round funds that labor as much as it funds model development.
Is Healthcare the Next Growth Engine?
Healthcare is the newer and less proven of the two businesses. Housing gave EliseAI its scale, while the company says healthcare front-office work shares the same traits: high call volume, repetitive tasks and staff shortages. The company has not published healthcare customer counts or revenue, so its traction there cannot be sized from public information.
Competition in clinic administration is crowded, with dedicated scheduling, intake and revenue cycle vendors plus electronic health record companies building their own agents. In property management, EliseAI's lead is clearer, though large software platforms in that sector also add AI features to their suites.
Strategic Context
The round fits a pattern of investors concentrating capital in AI application companies that show revenue. Agent-based automation for narrow operational workflows has drawn the largest checks, and buyers in fragmented, labor-heavy industries have been willing to pay for it. Housing and healthcare are the two largest household expenses in the United States, which explains the pitch. The harder test is whether customers keep paying as AI features become standard offerings from incumbents.
Outlook
EliseAI enters its next phase with a $4 billion valuation, more than $200 million in reported ARR and a mandate to prove its healthcare business can match its housing one. Revenue disclosure for the healthcare unit, retention as incumbents add competing agents, and the San Francisco engineering build-out are the main items to watch. A future IPO or acquisition would need growth to hold well above the pace typical for companies of that size.
